Lee Kalowski Homology Medicines, Inc. (FIXX) insider trading activity

FIXX Quotes by TradingView

Lee Kalowski is CFO and President of Homology Medicines, Inc.. Currently has a direct ownership of 49,010 shares of FIXX, which is worth approximately $0. The most recent transaction as insider was on Aug 26, 2025, when has been sold 4,240 shares (Common Stock) at a price of $1.8 per share, resulting in proceeds of $7,632. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 49K
7.96% 3M change
n/a 12M change
Total Value Held $0

Lee Kalowski Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 26 2025
SELL
Open market or private sale
$7,632 $1.8 p/Share
4,240 Reduced 7.96%
49,010 Common Stock
Feb 24 2025
BUY
Grant, award, or other acquisition
-
53,250 Added 50.0%
53,250 Common Stock

Also insider at

BCYC
BICYCLE THERAPEUTICS plc Healthcare
President and CFO
LK

Lee Kalowski

CFO and President
Cambridge, X0

Track Institutional and Insider Activities on FIXX

Follow Homology Medicines, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells FIXX shares.

Notify only if

Insider Trading

Get notified when an Homology Medicines, Inc. insider buys or sells FIXX shares.

Notify only if

News

Receive news related to Homology Medicines, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on FIXX